CEPHALEXIN (cephalexin) by Aurobindo Pharma is clinical pharmacology human pharmacology cephalexin tablets are acid stable and may be given without regard to meals. Approved for the following infections, streptococcus pyogenes otitis media due to susceptible isolates of streptococcu pneumoniae, haemophilus influenzae and 3 more indications. First approved in 2024.
Drug data last refreshed 20h ago
CLINICAL PHARMACOLOGY Human Pharmacology Cephalexin tablets are acid stable and may be given without regard to meals. It is rapidly absorbed after oral administration. Following doses of 250 mg, 500 mg, and 1 g, average peak serum levels of approximately 9, 18, and 32 mcg/mL, respectively, were…
Worked on CEPHALEXIN at Aurobindo Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Oral Amoxicillin and Cephalexin PK/PD in Neonates
Cefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal Infections
A Study of Cephalexin Liquid in Healthy Participants
A Study of Cephalexin Liquid for Pediatrics in Healthy Adults Participants
A Study of Cephalexin Suspension in Healthy Participants